1. Cai, Yuan, Zeng, Rong, Peng, Jinwu, Xu, Zhijie, Bai, Ning. 2022. The downregulated drug-metabolism related ALDH6A1 serves as predictor for prognosis and therapeutic immune response in gastric cancer. In Aging, 14, 7038-7051. doi:10.18632/aging.204270. https://pubmed.ncbi.nlm.nih.gov/36098688/
2. Wang, Hong, Dey, Kaushik Kumar, Chen, Ping-Chung, Beach, Thomas G, Peng, Junmin. 2020. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease. In Molecular neurodegeneration, 15, 43. doi:10.1186/s13024-020-00384-6. https://pubmed.ncbi.nlm.nih.gov/32711556/
3. Li, Xiang, Wang, Nan, Wu, Yutong, Liu, Yidan, Wang, Ruoyu. 2022. ALDH6A1 weakens the progression of colon cancer via modulating the RAS/RAF/MEK/ERK pathway in cancer cell lines. In Gene, 842, 146757. doi:10.1016/j.gene.2022.146757. https://pubmed.ncbi.nlm.nih.gov/35907565/
4. Marcadier, Julien L, Smith, Amanda M, Pohl, Daniela, Chakraborty, Pranesh, Geraghty, Michael T. 2013. Mutations in ALDH6A1 encoding methylmalonate semialdehyde dehydrogenase are associated with dysmyelination and transient methylmalonic aciduria. In Orphanet journal of rare diseases, 8, 98. doi:10.1186/1750-1172-8-98. https://pubmed.ncbi.nlm.nih.gov/23835272/
5. Liu, Song, Cai, Xiaojun, Wang, Tao, Wei, Gangjie, Yan, Shuang. 2022. Downregulation of ALDH6A1 is a New Marker of Muscle Insulin Resistance in Type 2 Diabetes Mellitus. In International journal of general medicine, 15, 2137-2147. doi:10.2147/IJGM.S343727. https://pubmed.ncbi.nlm.nih.gov/35241929/
智鼠故事 
